Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative submucosal dexamethasone for postoperative complications after mandibular third molar surgery
PACTR202603708240509Not yet recruiting
- Sponsor
- Dickson Afram
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of dexamethasone in Impacted lower third molar (2 arms), sponsored by Dickson Afram. Primary endpoint: Postoperative complications after mandibular third molar surgery. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
Impacted lower third molar
Beyond the preview
Go deeper on PACTR202603708240509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603708240509.